小RNA
炎症
表型
体内
免疫沉淀
荧光素酶
癌症研究
骨关节炎
下调和上调
非翻译区
NF-κB
分子生物学
化学
生物
受体
信使核糖核酸
细胞生物学
基因
转染
生物化学
医学
免疫学
遗传学
病理
替代医学
作者
Baoxi Yu,Anyu Zeng,Hailong Liu,Zhijian Yang,Ming Fu
标识
DOI:10.1016/j.bbrc.2022.09.103
摘要
MicroRNA (miRNA) is one of the most potent therapeutic targets for osteoarthritis (OA). We identified that miR-654-3p protected the phenotype of chondrocytes. We demonstrated that TNF receptor superfamily member 9 (TNFRSF9) was the target of miR-654-3p by binding to its 3'UTR regions, based on a dual-luciferase reporter assay and an RNA binding protein immunoprecipitation (RIP) assay. In addition, further experiments proved that TNFRSF9, as a trigger of the NF-κB pathway, correlated with the inflammation in chondrocytes. MiR-654-3p overexpressed in the knee of mice alleviated the OA in vivo. Moreover, we examined the m6A enzyme level in OA, proving that the abnormal expression of α-ketoglutarate-dependent dioxygenase alkB homolog 5 (ALKBH5) contributed to the miR-654-3p decrease. Our research illustrated the significant role of miR-654-3p in OA, including its maturation and the mechanism in protecting the phenotype of chondrocytes, which could be a new treatment target for OA.
科研通智能强力驱动
Strongly Powered by AbleSci AI